PPAR-γ has nowbecome the therapeutic target of research on kidney diseases like diabeticnephropathy, glomerulosclerosis, glomerulonephritis, and hypertensivenephropathy [2]. The gene discussed is PPARG; the disease is glomerulosclerosis.